Haohai Bioscience's net profit for 2025 was 251 million yuan, down 40.3% year-over-year

2026-03-23 08:46:21

Beijing Business Daily (Reporter Ding Ning) March 20th evening, Haohai Shengke (688366) released its 2025 annual report, showing that during the reporting period, the company achieved operating revenue of 2.473 billion yuan, a decrease of 8.33% year-on-year; net profit attributable to shareholders was 251 million yuan, a decrease of 40.3% year-on-year.

The annual report indicates that Haohai Shengke plans to distribute a cash dividend of 6 yuan (tax included) for every 10 shares to all shareholders, with a total expected distribution of 136 million yuan.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.